DILTIAZEM

Diltiazem Adverse Events Reported to the FDA Over Time

How are Diltiazem adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Diltiazem, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Diltiazem is flagged as the suspect drug causing the adverse event.

Most Common Diltiazem Adverse Events Reported to the FDA

What are the most common Diltiazem adverse events reported to the FDA?

Completed Suicide	938 (3.54%)
Bradycardia	532 (2.01%)
Hypotension	453 (1.71%)
Drug Interaction	419 (1.58%)
Cardiac Arrest	414 (1.56%)
Dizziness	393 (1.48%)
Nausea	358 (1.35%)
Overdose	303 (1.14%)
Blood Pressure Increased	287 (1.08%)
Atrial Fibrillation	275 (1.04%)
Dyspnoea	266 (1%)
	Show More
Asthenia	228 (.86%)
Oedema Peripheral	226 (.85%)
Malaise	215 (.81%)
Multiple Drug Overdose	197 (.74%)
Fatigue	190 (.72%)
Renal Failure Acute	182 (.69%)
Headache	181 (.68%)
Vomiting	181 (.68%)
Drug Ineffective	178 (.67%)
Diarrhoea	167 (.63%)
Respiratory Arrest	163 (.61%)
Heart Rate Decreased	161 (.61%)
Poisoning	159 (.6%)
Hyperkalaemia	144 (.54%)
Vision Blurred	144 (.54%)
Fall	143 (.54%)
Condition Aggravated	139 (.52%)
Loss Of Consciousness	139 (.52%)
Blood Creatinine Increased	136 (.51%)
Medication Error	136 (.51%)
Intentional Overdose	135 (.51%)
Palpitations	134 (.51%)
Blood Pressure Decreased	129 (.49%)
Pyrexia	129 (.49%)
Renal Failure	127 (.48%)
Syncope	126 (.48%)
Chest Pain	125 (.47%)
Atrioventricular Block Complete	122 (.46%)
Multiple Drug Overdose Intentional	122 (.46%)
Cardio-respiratory Arrest	119 (.45%)
Confusional State	119 (.45%)
Cardiogenic Shock	117 (.44%)
Abdominal Pain	116 (.44%)
Hypertension	115 (.43%)
Sinus Bradycardia	113 (.43%)
Acute Generalised Exanthematous Pus...	112 (.42%)
Blood Glucose Increased	112 (.42%)
Heart Rate Increased	112 (.42%)
Alanine Aminotransferase Increased	109 (.41%)
Drug Toxicity	109 (.41%)
Rhabdomyolysis	105 (.4%)
Drug Hypersensitivity	103 (.39%)
Aspartate Aminotransferase Increase...	102 (.38%)
Somnolence	102 (.38%)
Visual Impairment	101 (.38%)
Hypoaesthesia	100 (.38%)
Tremor	92 (.35%)
Vertigo	92 (.35%)
Nodal Rhythm	91 (.34%)
Rash	90 (.34%)
Dehydration	87 (.33%)
Blood Creatine Phosphokinase Increa...	83 (.31%)
Feeling Abnormal	83 (.31%)
Insomnia	81 (.31%)
Pruritus	78 (.29%)
Shock	78 (.29%)
Death	75 (.28%)
Hyperhidrosis	74 (.28%)
Intentional Drug Misuse	74 (.28%)
Pain	74 (.28%)
Gait Disturbance	73 (.28%)
Pneumonia	73 (.28%)
Metabolic Acidosis	72 (.27%)
Suicide Attempt	72 (.27%)
Myalgia	71 (.27%)
Depressed Level Of Consciousness	69 (.26%)
General Physical Health Deteriorati...	69 (.26%)
Blood Urea Increased	68 (.26%)
Erythema	68 (.26%)
Pulmonary Oedema	68 (.26%)
Incorrect Dose Administered	67 (.25%)
Renal Impairment	67 (.25%)
Abdominal Distension	66 (.25%)
Pain In Extremity	65 (.25%)
Product Substitution Issue	64 (.24%)
Back Pain	63 (.24%)
Cardiac Failure	63 (.24%)
Atrioventricular Block First Degree	62 (.23%)
Convulsion	62 (.23%)
Constipation	61 (.23%)
Haemoglobin Decreased	59 (.22%)
Multi-organ Failure	59 (.22%)
Arrhythmia	58 (.22%)
Arthralgia	58 (.22%)
Electrocardiogram Qt Prolonged	58 (.22%)
Muscular Weakness	58 (.22%)
Atrioventricular Block	57 (.21%)
Urticaria	57 (.21%)
Blood Pressure Inadequately Control...	56 (.21%)
Myocardial Infarction	56 (.21%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Diltiazem, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Diltiazem is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Diltiazem

What are the most common Diltiazem adverse events reported to the FDA?

Cardiac Arrhythmias	2515 (9.48%)
Neurological	1458 (5.5%)
Cardiac And Vascular Investigations	1165 (4.39%)
Medication Errors	1134 (4.28%)
Suicidal And Self-injurious Behavio...	1021 (3.85%)
Epidermal And Dermal Conditions	981 (3.7%)
Gastrointestinal Signs	963 (3.63%)
Respiratory	889 (3.35%)
Therapeutic And Nontherapeutic Effe...	820 (3.09%)
Decreased And Nonspecific Blood Pre...	741 (2.79%)
Renal Disorders	531 (2%)
	Show More
Electrolyte And Fluid Balance Condi...	387 (1.46%)
Chemical Injury And Poisoning	366 (1.38%)
Muscle	366 (1.38%)
Infections - Pathogen Unspecified	352 (1.33%)
Hematology Investigations	309 (1.17%)
Gastrointestinal Motility And Defec...	303 (1.14%)
Hepatobiliary	298 (1.12%)
Renal And Urinary Tract Investigati...	290 (1.09%)
Vision	278 (1.05%)
Hepatic And Hepatobiliary	276 (1.04%)
Coronary Artery	264 (1%)
Heart Failures	255 (.96%)
Injuries	255 (.96%)
Metabolic, Nutritional And Blood Ga...	247 (.93%)
Water, Electrolyte And Mineral	231 (.87%)
Headaches	227 (.86%)
Musculoskeletal And Connective Tiss...	207 (.78%)
Lower Respiratory Tract Disorders	206 (.78%)
Enzyme	204 (.77%)
Cardiac Disorder Signs	201 (.76%)
Allergic Conditions	189 (.71%)
Physical Examination Topics	180 (.68%)
Deliria	171 (.64%)
Joint	167 (.63%)
Anxiety Disorders	161 (.61%)
Urinary Tract Signs	148 (.56%)
Vascular Hypertensive	148 (.56%)
Movement Disorders	145 (.55%)
Body Temperature Conditions	143 (.54%)
Skin Appendage Conditions	141 (.53%)
Product Quality Issues	138 (.52%)
White Blood Cell	136 (.51%)
Myocardial	134 (.51%)
Acid-base	133 (.5%)
Psychiatric	128 (.48%)
Sleep Disorders	122 (.46%)
Glucose Metabolism Disorders	110 (.41%)
Lifestyle Issues	105 (.4%)
Inner Ear And Viiith Cranial Nerve	104 (.39%)
Toxicology And Therapeutic Drug Mon...	102 (.38%)
Bronchial Disorders	101 (.38%)
Gastrointestinal Hemorrhages	100 (.38%)
Vascular	100 (.38%)
Central Nervous System Vascular	97 (.37%)
Procedural And Device Related Injur...	97 (.37%)
Fatal Outcomes	93 (.35%)
Skin Vascular Abnormalities	93 (.35%)
Angiedema And Urticaria	92 (.35%)
Mental Impairment	88 (.33%)
Seizures	88 (.33%)
Hematological And Lymphoid Tissue T...	85 (.32%)
Dental And Gingival Conditions	76 (.29%)
Pleural	75 (.28%)
Anemias Nonhemolytic And Marrow Dep...	73 (.28%)
Bacterial Infectious	70 (.26%)
Ocular Infections, Irritations And ...	70 (.26%)
Appetite And General Nutritional	69 (.26%)
Eye	68 (.26%)
Oral Soft Tissue Conditions	67 (.25%)
Protein And Chemistry Analyses	62 (.23%)
Bone And Joint Injuries	61 (.23%)
Upper Respiratory Tract Disorders	57 (.21%)
Arteriosclerosis, Stenosis, Vascula...	54 (.2%)
Lipid Analyses	54 (.2%)
Platelet	50 (.19%)
Therapeutic Procedures And Supporti...	49 (.18%)
Gastrointestinal Inflammatory Condi...	47 (.18%)
Exocrine Pancreas Conditions	46 (.17%)
Viral Infectious	46 (.17%)
Ocular Neuromuscular	45 (.17%)
Mesotheliomas	44 (.17%)
Gastrointestinal Ulceration And Per...	43 (.16%)
Pulmonary Vascular	42 (.16%)
Respiratory And Mediastinal Neoplas...	42 (.16%)
Disturbances In Thinking	41 (.15%)
Cardiac Valve	40 (.15%)
Immunology And Allergy	40 (.15%)
Gallbladder	39 (.15%)
Depressed Mood Disorders	34 (.13%)
Gastrointestinal Conditions	34 (.13%)
Salivary Gland Conditions	34 (.13%)
Vascular Hemorrhagic	32 (.12%)
Thyroid Gland	31 (.12%)
Tongue Conditions	31 (.12%)
Changes In Physical Activity	30 (.11%)
Embolism And Thrombosis	28 (.11%)
Endocrine Investigations	28 (.11%)
Peripheral Neuropathies	28 (.11%)
Bone And Joint Therapeutic Procedur...	27 (.1%)
Coagulopathies And Bleeding Diathes...	27 (.1%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Diltiazem, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Diltiazem is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.